TAP Rapid Test Panel, Tapentadol abuse, Drugs of Abuse, detection of Tapentadol in Urine
Tapentadol is an opioid pain medication used to treat mod-erate to severe pain. It may be habit-forming, even at regular doses. A rapid test for the qualitative detection of Tapentadol in human urine.
For professional in vitro diagnostic use only
|TAP Rapid Test Panel, Tapentadol Abuse, Drugs Of Abuse, Detection Of Tapentadol In Urine
|Multiple Formats Available
The TAP Rapid Test Panel (Urine) is a rapid chromatographic immunoassay for the detection of Tapentadol in human urine at a cut-off concentration of 1000 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
• For professional in vitro diagnostic use only. Do not use after the expiration date.
• The test should remain in the sealed pouch until use.
• All specimens should be considered potentially hazardous and handled in the same manner as an infectious agent.
• The used test should be discarded according to local regulations.
SPECIMEN COLLECTION AND PREPARATION
The urine specimen must be collected in a clean and dry container. Urine collected at any time of the day may be used. Urine specimens exhibiting visible particles should be centrifuged, filtered or allowed to settle to obtain clear specimen for testing.
Urine specimens may be stored at 2-8 °C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20 °C. Frozen specimens should be thawedand mixed before testing.
DIRECTIONS FOR USE
Allow the test, urine specimen, and/or controls to reach room temperature (15-30 ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test panel from the sealed pouch and use it within one hour.
2. Remove the cap.
3. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the strip to at least the level of the wavy lines, but do not touch the plastic device.
4. Replace the cap and place the test panel on a non-absorbent flat surface.
5. Start the timer and wait for the colored line(s) to appear.
6. Read results at 5 minutes. Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
NEGATIVE:* Two colored lines appear. One colored line should be in the control line region (C), and another colored line should be in the test line region (T). A negative result indicates that the Tapentadol concentration is below the detectable level (1000 ng/mL).
*NOTE: The shade of color in the test line region (T) may vary, but it should be considered negative whenever there is even a faint colored line.
POSITIVE: One colored line appears in the control line region (C). No line appears in the test line region (T). A positive result indicates that the Tapentadol concentration exceeds the detectable level (1000 ng/mL).
INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test. If the problem persists, discontinue using the test kit immediately and contact local distributor.
Tapentadol is used to help relieve moderate to severe short-term pain such as pain from an injury or after surgery. It belongs to a class of drugs known as opioid analgesics. It works in the brain to change how the body feels and responds to pain.1 Tapentadol is mainly metabolized in the liver and is excreted by the kidneys in urine as well as in feces. The major pathway of metabolism is conjugation with glucuronic acid to produce glucuronides; tapentadol-O-glucuronide is the major metabolite.2 For monitoring the intake regularly, Tapentadol is tested in human urine. The TAP Rapid Test Panel (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Tapentadol in urine. The TAP Rapid Test Panel (Urine) yields a positive result when
Tapentadol in urine exceed 1000 ng/mL.